• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童和青少年代谢相关脂肪性肝病。

Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence.

机构信息

Cleveland Clinic Children's Department of Pediatric Gastroenterology Hepatology and Nutrition, 8950 Euclid Avenue, R Building, Cleveland, OH 44195, USA.

Department of Pediatric Endocrinology, Marshfield Clinic Health Systems, Marshfield Children's Hospital, 3rd Floor, 3D, 1000 North Oak Avenue, Marshfield, WI 54449, USA.

出版信息

Endocrinol Metab Clin North Am. 2023 Sep;52(3):417-430. doi: 10.1016/j.ecl.2023.02.001. Epub 2023 Mar 16.

DOI:10.1016/j.ecl.2023.02.001
PMID:37495334
Abstract

Metabolic-associated fatty liver disease (MAFLD) has become the most common cause for chronic liver disease among children and adolescents globally. Although liver biopsy remains the gold standard for diagnosis, emerging technology, like velocity controlled transient elastography, a noninvasive method, is being utilized to evaluate degree of fibrosis in these patients. The discovery of multiple gene polymorphisms has brought new hope for possible treatment targets. However, this research is still ongoing, making lifestyle changes and weight reduction the current mainstay of treatment. This review briefly reviews the most recent data regarding the epidemiology, pathophysiology, diagnostic modalities, and treatment of pediatric MAFLD.

摘要

代谢相关脂肪性肝病(MAFLD)已成为目前全球儿童和青少年慢性肝病的最常见病因。虽然肝活检仍然是诊断的金标准,但新兴技术,如速度控制的瞬时弹性成像,一种非侵入性的方法,正被用于评估这些患者的纤维化程度。多种基因多态性的发现为可能的治疗靶点带来了新的希望。然而,这项研究仍在进行中,生活方式的改变和体重的减轻仍然是目前治疗的主要方法。本文简要回顾了关于儿科 MAFLD 的流行病学、病理生理学、诊断方法和治疗的最新数据。

相似文献

1
Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence.儿童和青少年代谢相关脂肪性肝病。
Endocrinol Metab Clin North Am. 2023 Sep;52(3):417-430. doi: 10.1016/j.ecl.2023.02.001. Epub 2023 Mar 16.
2
Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的诊断和评估,包括无创生物标志物和瞬时弹性成像。
Clin Liver Dis. 2018 Feb;22(1):73-92. doi: 10.1016/j.cld.2017.08.004.
3
Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.当前和新兴的非酒精性脂肪性肝病生物标志物和影像学手段:临床和研究应用。
Clin Ther. 2021 Sep;43(9):1505-1522. doi: 10.1016/j.clinthera.2021.07.012. Epub 2021 Aug 13.
4
Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease.新兴的非酒精性脂肪性肝病的诊断方式和治疗方法。
Curr Gastroenterol Rep. 2020 Aug 19;22(10):52. doi: 10.1007/s11894-020-00786-y.
5
[New advances in diagnosis of nonalcoholic fatty liver disease].[非酒精性脂肪性肝病诊断的新进展]
Zhonghua Gan Zang Bing Za Zhi. 2016 Feb;24(2):85-8. doi: 10.3760/cma.j.issn.1007-3418.2016.02.002.
6
Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China.中国 HIV 感染者代谢相关脂肪性肝病的患病率及相关危险因素。
J Gastroenterol Hepatol. 2021 Jun;36(6):1670-1678. doi: 10.1111/jgh.15320. Epub 2021 Jan 19.
7
Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes.非酒精性脂肪性肝病和 2 型糖尿病患者的发病机制、筛查方式和治疗选择。
Diabet Med. 2020 Nov;37(11):1793-1806. doi: 10.1111/dme.14356. Epub 2020 Jul 13.
8
Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future.非酒精性脂肪性肝病肝纤维化的无创性影像学生物标志物:现状与展望。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S136-S149. doi: 10.3350/cmh.2022.0436. Epub 2022 Dec 12.
9
Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease.代谢相关脂肪性肝病新定义对该疾病流行病学的影响。
Clin Gastroenterol Hepatol. 2021 Oct;19(10):2161-2171.e5. doi: 10.1016/j.cgh.2020.10.046. Epub 2020 Oct 31.
10
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.肝活检及非侵入性诊断测试在非酒精性脂肪性肝病/非酒精性脂肪性肝炎诊断中的局限性
World J Gastroenterol. 2014 Jan 14;20(2):475-85. doi: 10.3748/wjg.v20.i2.475.

引用本文的文献

1
Epidemiological Dynamics of Burden and Health Inequalities in Metabolic Dysfunction-associated Steatotic Liver Disease in Adolescents at Global, Regional, and National Levels, 1990-2021.1990 - 2021年全球、区域和国家层面青少年代谢功能障碍相关脂肪性肝病负担及健康不平等的流行病学动态
J Clin Exp Hepatol. 2025 Jul-Aug;15(4):102537. doi: 10.1016/j.jceh.2025.102537. Epub 2025 Feb 28.
2
Machine Learning-Based predictive model for adolescent metabolic syndrome: Utilizing data from NHANES 2007-2016.基于机器学习的青少年代谢综合征预测模型:利用2007 - 2016年美国国家健康与营养检查调查(NHANES)的数据
Sci Rep. 2025 Jan 25;15(1):3274. doi: 10.1038/s41598-025-88156-4.
3
A positive relationship between weight-adjusted waist index and non-alcoholic fatty liver disease: a study on US adolescents.
体重调整腰围指数与非酒精性脂肪性肝病之间的正相关关系:一项针对美国青少年的研究。
Front Med (Lausanne). 2025 Jan 7;11:1424667. doi: 10.3389/fmed.2024.1424667. eCollection 2024.
4
Metabolic Dysfunction-associated Fatty Liver Disease: An Urgent Call for Global Action.代谢功能障碍相关脂肪性肝病:全球行动的紧急呼吁。
touchREV Endocrinol. 2024 Apr;20(1):5-9. doi: 10.17925/EE.2023.20.1.1. Epub 2023 Nov 8.
5
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Thyroid Function in Childhood Obesity: A Vicious Circle?儿童肥胖中的代谢功能障碍相关脂肪性肝病(MAFLD)与甲状腺功能:恶性循环?
Children (Basel). 2024 Feb 15;11(2):244. doi: 10.3390/children11020244.